- Our Mission
Enabling the discovery of next-generation therapeutic antibodies targeting complex membrane proteins.
Harnessing the power of our LASEREDD™ platform and antibody engineering to target G protein-coupled receptors (GPCRs) – We aim to deliver more effective and better-tolerated solutions that redefine the standard of care in obesity treatment.
Our team brings together leaders in antibody engineering, GPCR science, and drug development to tackle some of the most complex challenges in metabolic disease. Through a differentiated platform and rigorous scientific approach, we are building a pipeline of innovative therapeutics designed to deliver meaningful benefits for patients and healthcare systems worldwide.
- The Problem
GPCRs are the most targeted proteins in the human body, yet they still lack truly precise therapies. Small molecules and peptides lack selectivity; antibodies lack function.
- The Solution
Alkira Bio is changing this - by engineering biologics that are both precisely selective and functionally potent.
ALK 004
- About Alkira
Built by leaders in antibody discovery and drug development.
Daniel Scott
Founder & CEO
Chris Draper-Joyce
Founder & CSO
Jon Terrett
CXO
Antoine Henninot
Drug Maker
Greg Carven
CSO Partner
Andy Garner
CSO Partner
Our Team
L-R: Brad Hoare – Senior Scientist, Dan Scott – CEO, Saund Yadanar – Research Assistant, Lisa Williams – Senior Scientist, Eddy Yang – Senior Scientist
L-R: Riley Cridge – Operations Lead, Christina Chen – Research Assistant, Chris Draper-Joyce – CSO, Alastair Keen – Senior Scientist, Zoe Bell – Research Assistant
Our Team
L-R: Brad Hoare – Senior Scientist, Dan Scott – CEO, Saund Yadanar – Research Assistant, Lisa Williams – Senior Scientist, Eddy Yang – Senior Scientist
L-R: Riley Cridge – Operations Lead, Christina Chen – Research Assistant, Chris Draper-Joyce – CSO, Alastair Keen – Senior Scientist, Zoe Bell – Research Assistant
- Contact Us
Get in contact with us for more information regarding partnerships, investments, or to learn more about what we’re building.
- Partners & Supporters
